Distal nephrotoxicity of cisplatin demonstrated by urinary kallikrein excretion and morphological study in rats
- PMID: 1949042
- DOI: 10.1016/0300-483x(91)90225-p
Distal nephrotoxicity of cisplatin demonstrated by urinary kallikrein excretion and morphological study in rats
Abstract
The nephrotoxic effect of cisplatin (4 mg/kg body wt, i.p. injection) was specifically evaluated on the distal tubule. We measured both the tissue concentration and the urinary excretion of kallikrein (UKE), a serine protease mainly synthesized and secreted in the distal connecting tubular cells. In a parallel morphological study, we evaluated the tissue lesions. On the basis of UKE, the three distinct phases of nephrotoxicity were observed. The induction phase, 1 day after cisplatin injection, was associated with a transient increase in UKE. During the maintenance phase, the kallikrein concentration was significantly decreased both in renal cortex and urine for up to 10 days, suggesting an alteration in the biosynthesis with a decrease in the activation of inactive kallikrein. The recovery phase, 21 days after cisplatin injection, was suggested by the incomplete but significant tendency to return towards control values of active UKE. Histological examinations of cisplatin-treated rats showed early lesions of proximal tubules on day 1. The injuries worsened and tubular necrosis was frequently observed on the following days. Distal tubular changes were less marked but vacuolization and desquamation of epithelial cells and swollen and disrupted mitochondria were demonstrated. This study adds new evidence that UKE is a useful and reliable non-invasive index to assess possible nephrotoxic effects in the distal tubule which are also directly visualized by histological lesions.
Similar articles
-
Renal immunolocalization of kallikrein in cisplatin nephrotoxicity in rats.Histochem J. 1993 Oct;25(10):772-7. doi: 10.1007/BF00211772. Histochem J. 1993. PMID: 8282570
-
Inverse relationship between renal and urinary kallikrein during chromate-induced acute renal failure in rat: urinary kallikrein excretion as a possible recovery index.Biol Chem Hoppe Seyler. 1989 Dec;370(12):1305-13. doi: 10.1515/bchm3.1989.370.2.1305. Biol Chem Hoppe Seyler. 1989. PMID: 2619924
-
Renal kallikrein excretion as a distal nephrotoxicity marker during cadmium exposure in rats.Toxicology. 1989 Apr;55(1-2):117-29. doi: 10.1016/0300-483x(89)90179-0. Toxicology. 1989. PMID: 2652377
-
Cisplatin nephrotoxicity.Toxicol Lett. 1989 Mar;46(1-3):163-75. doi: 10.1016/0378-4274(89)90125-2. Toxicol Lett. 1989. PMID: 2650023 Review.
-
Cisplatin nephrotoxicity: experimental and clinical studies.Dan Med Bull. 1990 Feb;37(1):1-12. Dan Med Bull. 1990. PMID: 2178884 Review.
Cited by
-
Renal immunolocalization of kallikrein in cisplatin nephrotoxicity in rats.Histochem J. 1993 Oct;25(10):772-7. doi: 10.1007/BF00211772. Histochem J. 1993. PMID: 8282570
-
Evidence for intrarenal kallikrein storage during chromate-induced acute renal failure in rat.Histochemistry. 1992;97(3):293-301. doi: 10.1007/BF00267641. Histochemistry. 1992. PMID: 1563979
MeSH terms
Substances
LinkOut - more resources
Full Text Sources